Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TheraCal PT Pulpotomy in Primary Molars With Reversible Pulpitis
NCT07876934Not yet recruiting
- Start
- Jan 2027
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
Randomised, single-blind trial of sodium hypochlorite and ferric sulfate in reversible pulpitis and dental caries (3 arms). Primary endpoint: Overall Clinical Success Rate at 12 months. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
sodium hypochloriteferric sulfate
03
Conditions
reversible pulpitisdental caries
Beyond the preview
Go deeper on NCT07876934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07876934.